
- Telehealth Visits
- Insurance plan information

G. Michael Harper, MD
Geriatric Medicine- Telehealth Visits
- Insurance plan information



G. Michael Harper, MD
Geriatric Medicine- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. G. Michael Harper is a geriatrician who provides primary care to older homebound adults in San Francisco. As a clinician-teacher, he also trains medical students, residents and fellows. He serves as medical director for two San Francisco older adult communities: the Carlisle, an assisted living facility, and the Sequoias, a continuing care retirement community.
Harper earned his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a residency in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in geriatrics at the Johns Hopkins School of Medicine.
Harper serves on the executive committee and board of directors of the American Geriatrics Society.
Education & training
Board certification
- Geriatric Medicine, American Board of Internal Med/Geriatric Med
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Geriatric Medicine, Johns Hopkins Bayview Medical Center - GME
Residency
- Internal Medicine, Johns Hopkins Bayview Medical Center - GME
Internship
- Internal Medicine, Johns Hopkins Bayview Medical Center - GME
Degree
- MD, Robert Wood Johnson Medical School
My expertise
Specialties
Clinical Trials query: q=health_gateway_id_ss%3A%28%221249%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221249%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.